Perceptive Advisors LLC Astria Therapeutics, Inc. Transaction History
Perceptive Advisors LLC
- $2.28 Billion
- Q2 2025
A detailed history of Perceptive Advisors LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 6,485,420 shares of ATXS stock, worth $43.1 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
6,485,420
Previous 6,485,420
-0.0%
Holding current value
$43.1 Million
Previous $34.6 Million
0.37%
% of portfolio
1.53%
Previous 1.45%
Shares
6 transactions
Others Institutions Holding ATXS
# of Institutions
110Shares Held
49.3MCall Options Held
6.6KPut Options Held
0-
Vestal Point Capital, LP New York, NY4.52MShares$30.1 Million1.28% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.11MShares$27.3 Million6.34% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$23.6 Million5.84% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$23.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.97MShares$19.7 Million0.01% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $101M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...